The decreasing levels of inflammatory cytokines TNFα, IL-1β on the 28th day of follow-up in COVID-19 patients are consistent with the results of the study by Perpiñan et al., except in the case of IL-1β, which was increased at four–six weeks after admission in that study [37]. Here, IL1B is linked to COVID-19.